Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 10 , ISSUE 1 ( January-April, 2021 ) > List of Articles

Original Article

Endobronchial Biopsies in the Diagnosis of Lung Lesions — A Study of 204 Consecutive Cases from a Single Center in Southern India

Nirmala Jyothi, Monalisa Hui, Shantveer G. Uppin, N. Narendra Kumar, K. Bhaskar, G. K. Paramjyothi

Keywords : Bronchial wash, endobronchial biopsy, immunohistochemistry

Citation Information : Jyothi N, Hui M, Uppin SG, Kumar NN, Bhaskar K, Paramjyothi GK. Endobronchial Biopsies in the Diagnosis of Lung Lesions — A Study of 204 Consecutive Cases from a Single Center in Southern India. Indian J Respir Care 2021; 10 (1):57-65.

DOI: 10.4103/ijrc.ijrc_62_20

License: CC BY-NC-SA 4.0

Published Online: 06-12-2022

Copyright Statement:  Copyright © 2021; Indian Journal of Respiratory Care.


Objectives: The objective of this study is to evaluate the diagnostic yield of endobronchial biopsy in various neoplastic and nonneoplastic lung lesions. Patients and Methods: A total number of 204 consecutive cases of fiberoptic bronchoscopic-guided endobronchial biopsies was analyzed. The bronchial wash (BW) samples collected simultaneously during the biopsy were correlated with final histopathology diagnosis. Results: The bronchoscopic findings mainly included endobronchial mass, increased mucosal vascularity, and mucosal irregularities. Of the 184 adequate biopsy samples, 32.3% were neoplastic, 20.5% nonneoplastic, and remaining 41.3% revealed normal histology. The nonneoplastic lesions included mainly nonspecific inflammation, granulomatous inflammation followed by few cases of squamous metaplasia, one case each of tracheobronchopathia osteochondroplastica, mycobacterium spindle cell pseudotumor, and cytomegalovirus infection. Among the malignant tumors, adenocarcinoma (ADC) was the most common followed by squamous cell carcinoma (SQCC) and non-small cell carcinoma-not otherwise specified. On immunohistochemistry, Napsin-A showed better sensitivity than thyroid transcription factor-1 for ADC. P40 was found to be most sensitive and specific markers for SQCC. Neuroendocrine tumors included seven small cell carcinoma and three carcinoids. Both chromogranin and synaptophysin were found to be equally sensitive neuroendocrine markers. The bronchoscopically normal airways mostly revealed normal histology with few showing mild nonspecific inflammation. On the contrary, all except one case of neoplasm had mass lesions on bronchoscopy. Conclusion: EBB provides sufficient tissue for morphological and immunohistochemical characterization of malignant lesions. BW cytology has poor concordance with EBB in the diagnosis of malignancies with nearly 70% cases being false negative.

  1. Stevic R, Milenkovic B. Tracheobronchial tumors. J Thorac Dis 2016;8:3401-13.
  2. Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British thoracic society guideline for diagnostic flexible bronchoscopy in adults: Accredited by NICE. Thorax 2013;68 Suppl 1:i1-44.
  3. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85.
  4. Rosell A, Xaubet A, Agustí C, Castella J, Puzo C, Curull V, et al. A new BAL fluid instillation and aspiration technique: A multicenter randomized study. Respir Med 2006;100:529-35.
  5. Gibson PG, Breit SN, Bryant DH. Hypoxia during bronchoalveolar lavage. Aust N Z J Med 1990;20:39-43.
  6. Carr IM, Koegelenberg CF, von Groote-Bidlingmaier F, Mowlana A, Silos K, Haverman T, et al. Blood loss during flexible bronchoscopy: A prospective observational study. Respiration 2012;84:312-8.
  7. Leiten EO, Martinsen EM, Bakke PS, Eagan TM, Grønseth R. Complications and discomfort of bronchoscopy: A systematic review. Eur Clin Respir J 2016;3:33324.
  8. Ghazarian Z, Alziadat M, Sekhon R, Hanna M, Pandya T, Ismail M. Diagnostic yield of bronchoscopic lung biopsy in evaluating lung cancer. Chest 2016;150:710A.
  9. Bhadke B, Munje R, Mahadani J, Surjushe A, Jalgaonkar P. Utility of fiberoptic bronchoscopy in diagnosis of various lung conditions: Our experience at rural medical college. Lung India 2010;27:118-21.
  10. Altin S, Cikrikçioğlu S, Morgül M, Koşar F, Ozyurt H. 50 endobronchial tuberculosis cases based on bronchoscopic diagnosis. Respiration 1997;64:162-4.
  11. Naber JM, Palmer SM, Howell DN Cytomegalovirus infection presenting as bronchial polyps in lung transplant recipients. J Heart Lung Transplant 2005;24:2109-13.
  12. Boylan KE, Larsen BT, Young BA, Downs-Kelly E, Panchabhai TS, Collum ES, et al. Pulmonary mycobacterial spindle cell pseudotumor: A report of 3 cases including a practical approach to histopathologic recognition of this unusual entity. Int J Surg Pathol 2018;26:629-34.
  13. Zhang X, Wu L, Xu Y, Zhang B, Wu X, Wang Y, et al. Trends in the incidence rate of lung cancer by histological type and gender in Sichuan, China, 1995-2015: A single-center retrospective study. Thorac Cancer 2018;9:532-41.
  14. Tacha D, Bremer R, Haas T, Qi W. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers. Arch Pathol Lab Med 2014;138:1358-64.
  15. Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011;35:15-25.
  16. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 2012;25:405-15.
  17. Ming-Hui AO, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, et al. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non–small cell lung cancer, Hum Pathol 2014;45:926-34.
  18. Dvorak K, Yambert J, Palting J, Reinhardt K, Roessler C, Moh A, et al. Improved lung cancer classification using new optimized immunohistochemical assay with anti-p40 (BC28) mouse monoclonal antibody. Int J Clin Exp Pathol 2016;9:2693-01.
  19. Rekhtmann N. Neuroendocrine tumors of the lung. Arch Pathol Lab Med 2010;134:1628-38.
  20. Beasley MB, Thunnissen FB, Brambilla E, Hasleton P, Steele R, Hammar SP, et al. Pulmonary atypical carcinoid: Predictors of survival in 106 cases. Hum Pathol 2000;31:1255-65.
  21. Hiroshima K, Iyoda A, Shida T, Shibuya K, Iizasa T, Kishi H, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol 2006;19:1358-68.
  22. Rabahi MF, Ferreira AA, Reciputti BP, Matos Tde O, Pinto SA. Fiberoptic bronchoscopy findings in patients diagnosed with lung cancer. J Bras Pneumol 2012;38:445-51.
  23. Dobler CC, Crawford AB. Bronchoscopic diagnosis of endoscopically visible lung malignancies: Should cytological examinations be carried out routinely? Intern Med J 2009;39:806-11.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.